This section contains the latest information and guidance for health professionals on the swine flu vaccination programme.
On 8 December, Health Secretary Andy Burnham announced that the swine flu vaccination programme would be extended to children between the ages of six months and five years. This age group was identified as the next priority group for the vaccine because they are more likely to be hospitalised if they fall ill with swine flu. The licence has been amended to allow a one dose schedule in children.
Ian Dalton, National Director for NHS Flu Resilience, has today written to chief executives of primary care trusts in England to update them on plans for phase two of the swine flu vaccination programme.
The Department of Health has today (19 November 2009) announced that the swine flu vaccination programme will be extended to offer children over six months and under five protection against the virus.
This document has been developed to answer frequently asked questions relating to the supply of the swine flu vaccine and the ordering of further stocks via the ImmForm website.
A practical guide for health professionals.
This letter, further to the one sent on 15th October and following the start of the vaccination programme on 21 October, sets out additional information relevant to the campaign.
The Secretary of State Directions requiring Primary Care Trusts to enter into arrangements to vaccinate patients identified in the Chief Medical Officer's letter of 13 August 2009 come into force on 30 October 2009.
Letter from Ian Dalton, National Director of NHS Flu Resilience, Department of Health, requesting assistance in the vaccination of Health Protection Agency staff.
Information for clinicians about swine flu vaccination from Professor Sir Bruce Keogh.
Letter from the Chief Pharmaceutical Officer.
Letter from Roy Taylor, National Director for Social Care Flu Resilience, to help Directors of Adult Social Services in vaccination planning.
Letter from Sir Liam Donaldson, Chief Medical Officer, Dame Christine Beasley, Chief Nursing Officer and Dr Keith Ridge, Chief Pharmaceutical Officer providing information for clinicians in delivering the swine flu (influenza A (H1N1v) 2009) vaccination programme.
A letter from Ian Dalton, National Director of NHS Flu Resilience, to NHS Chief Executives, providing further information on the swine flu vaccination programme.
This video, which has been updated since its launch on 8 October 2009,shows how to prepare the swine flu vaccines for adults prior to administration. It complements existing vaccination training.
A letter from June Boggis, Head of the Vaccine Supply and Finance Team, on ordering and collecting uptake data for the swine flu vaccine.
Letter from Professor David Salisbury, Director of Immunisation, providing information to assist in further planning for the swine flu (influenza A (H1N1v) 2009) vaccination programme.
Following negotiations with the BMA General Practitioners Committee (GPC) to agree how the swine flu vaccine will be delivered, Ian Dalton, National Director of NHS Flu Resilience, has today written to all NHS Chief Executives to share the detail of the agreement and set out clear next steps. The vaccination programme will begin once the European Medicines Agency (EMEA) license the vaccines.
Following negotiations with the BMA General Practitioners Committee (GPC) to agree how the swine flu vaccine will be delivered, Ian Dalton, National Director of NHS Flu Resilience, has today written to all NHS Chief Executives to share the detail of the agreement and set out clear next steps. The vaccination programme will begin once the European Medicines Agency (EMEA) license the vaccines.
Accepting advice from independent expert committees, including the Joint Committee for Vaccination and Immunisation (JCVI) and the Scientific Advisory Group for Emergencies (SAGE), Health Secretary Andy Burnham has today announced the priority groups for vaccination against swine flu.